Tackling Data Fatigue: Dexcom Acquires Nutrisense and Unveils AI-Powered Stelo

Can too much health data be a bad thing? After a year-long experiment with continuous glucose monitors (CGMs) left users feeling overwhelmed, Dexcom is pivoting to a smarter approach. The company announced its acquisition of Nutrisense, a startup focused on non-diabetic users, to broaden its reach in the wellness market.

Simultaneously, Dexcom’s over-the-counter CGM, Stelo, is receiving an FDA-cleared redesign. This update integrates advanced pattern recognition and proactive AI coaching, providing personalized daily and weekly summaries. These features aim to transform raw glucose numbers into actionable insights, addressing the ‘data fatigue’ often experienced by health enthusiasts.

By combining Nutrisense’s platform with Stelo’s new AI capabilities, Dexcom is moving beyond simple tracking toward a more holistic, guided health experience for the general public.